BioCentury
ARTICLE | Finance

Kurma’s Munich move

How French VC Kurma plans to turn German research into biotechs

January 25, 2019 11:41 PM UTC

Kurma Partners has opened a Munich office to spin out German academic science into biotechs in a bid to apply its company creation model to bridge the country’s venture capital gap for translating compelling research.

The new office reflects Kurma's shift to a pan-European incubation strategy with its Biofund III, for which the Paris-based firm raised an undisclosed amount in a first close announced in December. For its prior fund, the VC sought to connect French academic groups with an industry collaborator prior to building new companies (see “Spreading Good Kurma”)...

BCIQ Company Profiles

Kurma Partners S.A.